404 related articles for article (PubMed ID: 26493334)
1. Influence of Diabetes Mellitus and Cigarette Smoking on Variability of the Clopidogrel-Induced Antiplatelet Effect and Efficacy of Active Management of the Target P2Y12 Reaction Unit Range in Patients Undergoing Neurointerventional Procedures.
Nakagawa I; Park HS; Yokoyama S; Wada T; Hironaka Y; Motoyama Y; Takayama K; Kichikawa K; Nakase H
J Stroke Cerebrovasc Dis; 2016 Jan; 25(1):163-71. PubMed ID: 26493334
[TBL] [Abstract][Full Text] [Related]
2. Platelet inhibition by adjunctive cilostazol suppresses the frequency of cerebral ischemic lesions after carotid artery stenting in patients with carotid artery stenosis.
Nakagawa I; Wada T; Park HS; Nishimura F; Yamada S; Nakagawa H; Kichikawa K; Nakase H
J Vasc Surg; 2014 Mar; 59(3):761-7. PubMed ID: 24239116
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of cilostazol-based dual antiplatelet treatment in patients undergoing carotid artery stenting.
Nakagawa I; Park HS; Wada T; Yokoyama S; Yamada S; Motoyama Y; Kichikawa K; Nakase H
Neurol Res; 2017 Aug; 39(8):695-701. PubMed ID: 28290236
[TBL] [Abstract][Full Text] [Related]
4. Adding cilostazol to dual antiplatelet therapy achieves greater platelet inhibition than high maintenance dose clopidogrel in patients with acute myocardial infarction: Results of the adjunctive cilostazol versus high maintenance dose clopidogrel in patients with AMI (ACCEL-AMI) study.
Jeong YH; Hwang JY; Kim IS; Park Y; Hwang SJ; Lee SW; Kwak CH; Park SW
Circ Cardiovasc Interv; 2010 Feb; 3(1):17-26. PubMed ID: 20118150
[TBL] [Abstract][Full Text] [Related]
5. Cigarette smoking is associated with a dose-response effect in clopidogrel-treated patients with diabetes mellitus and coronary artery disease: results of a pharmacodynamic study.
Ueno M; Ferreiro JL; Desai B; Tomasello SD; Tello-Montoliu A; Capodanno D; Capranzano P; Kodali M; Dharmashankar K; Charlton RK; Bass TA; Angiolillo DJ
JACC Cardiovasc Interv; 2012 Mar; 5(3):293-300. PubMed ID: 22440495
[TBL] [Abstract][Full Text] [Related]
6. Platelet reactivity and hemorrhage risk in neurointerventional procedures under dual antiplatelet therapy.
Nishi H; Nakahara I; Matsumoto S; Hashimoto T; Ohta T; Sadamasa N; Ishibashi R; Gomi M; Saka M; Miyata H; Watanabe S; Okata T; Sonoda K; Kouge J; Ishii A; Nagata I; Kira J
J Neurointerv Surg; 2016 Sep; 8(9):949-53. PubMed ID: 26297788
[TBL] [Abstract][Full Text] [Related]
7. Variability in initial response to standard clopidogrel therapy, delayed conversion to clopidogrel hyper-response, and associated thromboembolic and hemorrhagic complications in patients undergoing endovascular treatment of unruptured cerebral aneurysms.
Delgado Almandoz JE; Kadkhodayan Y; Crandall BM; Scholz JM; Fease JL; Tubman DE
J Neurointerv Surg; 2014 Dec; 6(10):767-73. PubMed ID: 24353331
[TBL] [Abstract][Full Text] [Related]
8. Clopidogrel response variability is associated with endothelial dysfunction in coronary artery disease patients receiving dual antiplatelet therapy.
Siasos G; Oikonomou E; Zaromitidou M; Kioufis S; Kokkou E; Mourouzis K; Vlasis K; Vavuranakis M; Stone PH; Papavassiliou AG; Tousoulis D
Atherosclerosis; 2015 Sep; 242(1):102-8. PubMed ID: 26188531
[TBL] [Abstract][Full Text] [Related]
9. Influence of smoking on the antiplatelet effect of clopidogrel differs according to clopidogrel dose: Insights from the GRAVITAS trial.
Reed GW; Cannon CP; Waalen J; Teirstein PS; Tanguay JF; Berger PB; Angiolillo DJ; Price MJ
Catheter Cardiovasc Interv; 2017 Feb; 89(2):190-198. PubMed ID: 26909669
[TBL] [Abstract][Full Text] [Related]
10. Antiplatelet effects of clopidogrel dose adjustment (75 mg/d vs 150 mg/d) after carotid stenting.
González A; Moniche F; Cayuela A; Gonzalez-Marcos JR; Mayol A; Montaner J
J Vasc Surg; 2014 Aug; 60(2):428-35. PubMed ID: 24629989
[TBL] [Abstract][Full Text] [Related]
11. Multi-institutional patterns of clopidogrel response among patients undergoing transcarotid artery revascularization.
Rokosh RS; Rockman C; Garg K; Wang SK; Motaganahalli RL; Schroeder AC; Sobraske PJ; Stoner MC; Tarbunou YA; Marmor RA; Malas MB; Maldonado TS
Vascular; 2024 Jun; 32(3):558-564. PubMed ID: 36428145
[TBL] [Abstract][Full Text] [Related]
12. Determination of the prevalence of aspirin and clopidogrel resistances in patients with coronary artery disease by using various platelet-function tests.
Woo KS; Kim BR; Kim JE; Goh RY; Yu LH; Kim MH; Han JY
Korean J Lab Med; 2010 Oct; 30(5):460-8. PubMed ID: 20890076
[TBL] [Abstract][Full Text] [Related]
13. P2Y
Kim CH; Hwang G; Kwon OK; Ban SP; Chinh ND; Tjahjadi M; Oh CW; Bang JS; Kim T
Radiology; 2017 Feb; 282(2):542-551. PubMed ID: 27603789
[TBL] [Abstract][Full Text] [Related]
14. Triple antiplatelet therapy with addition of cilostazol to aspirin and clopidogrel for Y-stent-assisted coil embolization of cerebral aneurysms.
Kono K; Shintani A; Yoshimura R; Okada H; Tanaka Y; Fujimoto T; Tomura N; Terada T
Acta Neurochir (Wien); 2013 Aug; 155(8):1549-57. PubMed ID: 23715948
[TBL] [Abstract][Full Text] [Related]
15. Impaired responsiveness to the platelet P2Y12 receptor antagonist clopidogrel in patients with type 2 diabetes and coronary artery disease.
Angiolillo DJ; Jakubowski JA; Ferreiro JL; Tello-Montoliu A; Rollini F; Franchi F; Ueno M; Darlington A; Desai B; Moser BA; Sugidachi A; Guzman LA; Bass TA
J Am Coll Cardiol; 2014 Sep; 64(10):1005-14. PubMed ID: 25190236
[TBL] [Abstract][Full Text] [Related]
16. Detection of clopidogrel hyporesponsiveness using a point-of-care assay and the impact of additional cilostazol administration after coronary stent implantation in diabetic patients.
Yang TH; Kim DI; Kim DK; Jang JS; Kim U; Seol SH; Kim DK; Hong GR; Park JS; Shin DG; Kim YJ; Cho YK; Nam CW; Hur SH; Kim KB; Kim DS
Korean J Intern Med; 2011 Jun; 26(2):145-52. PubMed ID: 21716590
[TBL] [Abstract][Full Text] [Related]
17. Randomized comparison of adjunctive cilostazol versus high maintenance dose clopidogrel in patients with high post-treatment platelet reactivity: results of the ACCEL-RESISTANCE (Adjunctive Cilostazol Versus High Maintenance Dose Clopidogrel in Patients With Clopidogrel Resistance) randomized study.
Jeong YH; Lee SW; Choi BR; Kim IS; Seo MK; Kwak CH; Hwang JY; Park SW
J Am Coll Cardiol; 2009 Mar; 53(13):1101-9. PubMed ID: 19324253
[TBL] [Abstract][Full Text] [Related]
18. Platelet inhibition by adjunctive cilostazol versus high maintenance-dose clopidogrel in patients with acute myocardial infarction according to cytochrome P450 2C19 genotype.
Kim IS; Jeong YH; Park Y; Park KS; Yun SE; Park JR; Hwang SJ; Koh EH; Kwak CH; Hwang JY; Kim S
JACC Cardiovasc Interv; 2011 Apr; 4(4):381-91. PubMed ID: 21511217
[TBL] [Abstract][Full Text] [Related]
19. Routine assessment of on-clopidogrel platelet reactivity and gene polymorphisms in predicting clinical outcome following drug-eluting stent implantation in patients with stable coronary artery disease.
Viviani Anselmi C; Briguori C; Roncarati R; Papa L; Visconti G; Focaccio A; De Micco F; Latronico MV; Pagnotta P; Condorelli G
JACC Cardiovasc Interv; 2013 Nov; 6(11):1166-75. PubMed ID: 24262617
[TBL] [Abstract][Full Text] [Related]
20. The future of platelet function testing to guide therapy in clopidogrel low and enhanced responders.
Bernlochner I; Byrne RA; Kastrati A; Sibbing D
Expert Rev Cardiovasc Ther; 2011 Aug; 9(8):999-1014. PubMed ID: 21878045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
